- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05280847
Analysis of Injectate Spread During Erector Spinae Block
December 16, 2022 updated by: Ji Hee Hong, Keimyung University Dongsan Medical Center
Comparison of the Spread Level During Thoracic Erector Spinae Plane Block Using Two Volumes of Local Anesthetics
The primary purpose of this study was to identify the ESPB spread level in the craniocaudal direction when performed at the T2 level.
The secondary purpose was to determine the incidence of spread into epidural, paravertebral, intercostal, and intravascular injections with ESPB
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The ESPB requires ultrasound guidance which enables visible local anesthetic spread underneath the erector spinae muscles.
The spinalis, longissimus thoracis, and iliocostalis muscles comprise the ES muscles, which run vertically along both sides of the vertebral column from the sacrum up to the skull base.
The ESPB can be performed in the cervical, thoracic, and lumbar regions.
Among them, upper or mid thoracic ESPB has been used more widely compared to cervical and lumbar regions.
Previous cadaveric studies on the ESPB at the T5 level using computed tomography (CT) reconstruction or direct dissection demonstrated the extensive craniocaudal distribution of methylene blue ranging from T1 to T8 vertebral segments deep to the ES muscles and variable involvement of epidural, paravertebral, and intercostal spaces.
The ESPB performed at the T2 level of the cadaver demonstrated an injected dye distribution ranging from C4 to T10.
Also, 36% of cadavers showed the spread of an injected dye to the ventral, dorsal ramus, paravertebral space, and even the contralateral side.
The exact mechanism of action of ESPB remains unclear.
A recent study suggested that the analgesic effect of ESPB could be obtained by blocking the ventral and dorsal ramus of the spinal nerves by passing through the costotransverse foramen.
However, in clinical practice, we can encounter highly variable clinical outcomes or sensory block after the ESPB.
The study of the physical spread of the injected agent can be used to predict the clinical result and elucidate the possible mechanism of action of ESPB.
Study Type
Interventional
Enrollment (Actual)
159
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Daegu, Korea, Republic of, 42601
- Hong ji HEE
-
Daegu, Korea, Republic of, 700712
- Ji Hee Hong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Cervical facet joint arthrosis
- Cervical foraminal stenosis
- Cervical herniated intervertebral disc
- myofascial pain syndrome of upper back muscle
Exclusion Criteria:
- Allergy to local anesthetics or contrast medium
- Pregnancy
- Prior history of cervical spine surgery
- Coagulation abnormality
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 10 ml ESP group
ESP group using 10 ml mixture of local anesthetics and contrast medium using ultrasound and fluoroscopy
|
fascial plane injection using ultrasound and fluoroscopic guidance
Other Names:
|
Experimental: 20 ml ESP group
ESP group using 20 ml mixture of local anesthetics and contrast medium using ultrasound and fluoroscopy
|
fascial plane injection using ultrasound and fluoroscopic guidance
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
spread level in the cranio-caudal direction
Time Frame: baseline, 1 minutes after erector spinae plane block
|
fluoroscopic contrast medium spread level in the cranio-caudal direction
|
baseline, 1 minutes after erector spinae plane block
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participant showing epidural spread
Time Frame: baseline, 1 minute after erector spinae plane block
|
Number of participant showing epidural spread by analysis of fluoroscopic image
|
baseline, 1 minute after erector spinae plane block
|
Number of participant showing paravertebral spread
Time Frame: baseline, 1 minute after erector spinae plane block
|
Number of participant showing paravertebral spread by analysis of fluorosocpic image
|
baseline, 1 minute after erector spinae plane block
|
Number of participant showing intercostal spread
Time Frame: baseline, 1 minute after erector spinae plane block
|
Number of participant showing intercostal spread by analysis of fluoroscopic image
|
baseline, 1 minute after erector spinae plane block
|
Number of participant showing intravascular spread
Time Frame: baseline, 1 minute after erector spinae plane block
|
Number of participants showing intravascular spread by analysis of fluoroscopic image
|
baseline, 1 minute after erector spinae plane block
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 21, 2022
Primary Completion (Actual)
October 30, 2022
Study Completion (Actual)
October 30, 2022
Study Registration Dates
First Submitted
February 10, 2022
First Submitted That Met QC Criteria
March 5, 2022
First Posted (Actual)
March 15, 2022
Study Record Updates
Last Update Posted (Actual)
December 20, 2022
Last Update Submitted That Met QC Criteria
December 16, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
Clinical Trials on Erector spinae plane block
-
Stanford UniversityNot yet recruitingAnesthesia, Local | Anesthesia | Microtia | Microtia, CongenitalUnited States
-
Soroka University Medical CenterUnknown
-
Assiut UniversityCompletedRenal Stone | Percutaneous | NephrolithotomyEgypt
-
National Taiwan University HospitalRecruiting
-
Ain Shams UniversityRecruiting
-
National Cancer Institute, EgyptRecruiting
-
Cairo UniversityRecruitingPost-thoracotomy Pain SyndromeEgypt
-
Ankara City Hospital BilkentCompletedErector Spinae Plane Block | Heart Rate | Mean Arterial Pressure | Video-Assisted Thoracoscopic SurgeryTurkey
-
Ben marzouk SofieneCompletedBreast Cancer Surgery | Postoperative AnalgesiaTunisia
-
University of California, San FranciscoRecruitingErector Spinae Plane Block | Lumbar Spine SurgeryUnited States